Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5272723
Max Phase: Preclinical
Molecular Formula: C20H24O3S2
Molecular Weight: 376.54
Associated Items:
ID: ALA5272723
Max Phase: Preclinical
Molecular Formula: C20H24O3S2
Molecular Weight: 376.54
Associated Items:
Canonical SMILES: OCCSC(SCCO)c1ccc2c(c1)CCC(c1ccccc1)O2
Standard InChI: InChI=1S/C20H24O3S2/c21-10-12-24-20(25-13-11-22)17-7-9-19-16(14-17)6-8-18(23-19)15-4-2-1-3-5-15/h1-5,7,9,14,18,20-22H,6,8,10-13H2
Standard InChI Key: WYYMNFXBVYNCLA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 376.54 | Molecular Weight (Monoisotopic): 376.1167 | AlogP: 4.20 | #Rotatable Bonds: 8 |
Polar Surface Area: 49.69 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.94 | CX LogD: 3.94 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.68 | Np Likeness Score: 0.47 |
1. Lepechkin-Zilbermintz V, Bareket D, Gonnord V, Steffen A, Morice C, Michaut M, Munder A, Korshin EE, Contreras JM, Cerasi E, Sasson S, Gruzman A.. (2023) Moderately lipophilic 2-(Het)aryl-6-dithioacetals, 2-phenyl-1,4-benzodioxane-6-dithioacetals and 2-phenylbenzofuran-5-dithioacetals: Synthesis and primary evaluation as potential antidiabetic AMPK-activators., 87 [PMID:37167713] [10.1016/j.bmc.2023.117303] |
Source(1):